Resona Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,673
Closed -$541K 820
2025
Q3
$541K Sell
8,673
-432
-5% -$30.1K ﹤0.01% 688
2025
Q2
$727K Hold
9,105
﹤0.01% 660
2025
Q1
$783K Buy
9,105
+203
+2% +$16.7K ﹤0.01% 652
2024
Q4
$695K Hold
8,902
﹤0.01% 675
2024
Q3
$642K Hold
8,902
﹤0.01% 683
2024
Q2
$613K Sell
8,902
-649
-7% -$44K ﹤0.01% 686
2024
Q1
$693K Buy
+9,551
New +$639K ﹤0.01% 691

Other funds holding PBH

Resona Asset Management's PBH Position: Q4 2025 in Review

Resona Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q4 2025, closing a stake of 8,673 shares — an estimated $541K sold.

Resona Asset Management first reported a position in PBH in Q1 2024 and held it in 7 quarters. The position peaked at $783K in Q1 2025. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • Resona Asset Management reported no remaining Prestige Consumer Healthcare position as of Q4 2025 after selling out during the quarter.
  • Resona Asset Management sold 8,673 Prestige Consumer Healthcare shares in Q4 2025, an estimated $541K.
  • Resona Asset Management first reported a position in Prestige Consumer Healthcare in Q1 2024 and held it in 7 quarters.
  • Resona Asset Management's Prestige Consumer Healthcare position peaked at $783K in Q1 2025.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on Resona Asset Management's 13F filing for Q4 2025, filed 6 Feb 2026.